Not applicableActive Not RecruitingNCT07348718What this trial is testingRubix LS Diabetic Kidney Disease (DKD) Registry StudyWho this might be right forDiabetic Kidney Disease (DKD) Rubix LS 2,000
Not applicableStudy completedNCT05640180What this trial is testingAn Observational Study Called FLAMINgO to Learn More About the Treatment Combination of Finerenone and SGLT2 Inhibitors in People With Long-term Kidney Disease (Chronic Kidney Disease) Together With Type 2 Diabetes by Using Routine Medical Care Data and Past Clinical Study ResultsWho this might be right forChronic Kidney DiseaseType 2 Diabetes Bayer 17,847
Testing effectiveness (Phase 2)Study completedNCT05536804What this trial is testingTirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 DiabetesWho this might be right forOverweightObesityChronic Kidney Disease+2 more Eli Lilly and Company 134
Not applicableLooking for participantsNCT07434791What this trial is testingGoal-Directed Therapy to Reduce Kidney and Cardiovascular Risk in Diabetic Kidney Disease (GOLD-STANDARD)Who this might be right forDiabetic Kidney Disease (DKD)Type 2 Diabetes Mellitus (T2DM)Chronic Kidney Disease Sunnybrook Health Sciences Centre 100
Not applicableLooking for participantsNCT06838416What this trial is testingEvaluation of the Effect of Finerenone on Renal Function in Patients With Type 2 Diabetes and Chronic Kidney DiseaseWho this might be right forType 2 Diabetes MellitusChronic Kidney DiseaseRenal Function Second Affiliated Hospital of Soochow University 300
Not applicableLooking for participantsNCT05881447What this trial is testingPrevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan AfricaWho this might be right forChronic Kidney DiseasesType 2 Diabetes MellitusArterial Hypertension+8 more Swiss Tropical & Public Health Institute 1,200
Post-approval studies (Phase 4)Not Yet RecruitingNCT07116928What this trial is testingGanagliflozin on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney DiseaseWho this might be right forT2DM (Type 2 Diabetes Mellitus)CKD - Chronic Kidney Disease Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 1,244
Not applicableStudy completedNCT04361097What this trial is testingFecal Microbiota Transplantation as a Therapeutic Strategy in the Progression of Chronic Kidney DiseaseWho this might be right forChronic Kidney Disease Due to HypertensionChronic Kidney Disease Due to Type 2 Diabetes Mellitus Hospital Universitario Dr. Jose E. Gonzalez 28
Not applicableUnknownNCT04998461What this trial is testingImpact of Obesity, Chronic Kidney Disease and Type 2 Diabetes on Human Urinary Stem CellsWho this might be right forChronic Kidney DiseasesObesityStem Cells+1 more Hospices Civils de Lyon 60
Testing effectiveness (Phase 2)WithdrawnNCT04661917What this trial is testingA Trial to Learn More About How BAY2327949 Works and How Safe it is in Patients Whose Kidneys Are Damaged Due to High Blood Sugar Levels or High Blood Pressures, and With a Further Disease of the Heart or the Blood Vessels.Who this might be right forChronic Kidney DiseaseDiabetic Kidney Disease Bayer
Large-scale testing (Phase 3)Study completedNCT03242018What this trial is testingEvaluate Safety and Effects of Sotagliflozin 400 and 200 mg on Glucose Control in Participants With Type 2 Diabetes, Severe Impairment of Kidney Function and Inadequate Blood Sugar ControlWho this might be right forType 2 Diabetes MellitusChronic Kidney Disease Stage 4 Lexicon Pharmaceuticals 277
Large-scale testing (Phase 3)Active Not RecruitingNCT06383390What this trial is testingThe Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)Who this might be right forAtherosclerotic Cardiovascular Disease (ASCVD)Chronic Kidney Disease (CKD) Eli Lilly and Company 10,000
Early research (Phase 1)Study completedNCT06942923What this trial is testingInvestigate the Safety, Tolerability and Pharmacodynamics of AZD4144 in Participants With ObesityWho this might be right forHealthy Participants AstraZeneca 28
Large-scale testing (Phase 3)Not Yet RecruitingNCT07598864What this trial is testing"Dapagliflozin vs Dapagliflozin-Finerenone for Albuminuria in CKD With Type 2 Diabetes"Who this might be right forDiabetic Nephropathy Chittagong Medical College 88
Not applicableActive Not RecruitingNCT04960514What this trial is testingProspective Decision Impact Trial of KidneyIntelXWho this might be right forDiabetic Kidney DiseaseChronic Kidney Disease Stage 1Chronic Kidney Disease Stage 2+1 more Renalytix AI, Inc. 2,000
Not applicableNot Yet RecruitingNCT07422532What this trial is testingA Multi-centre Trial to Assess the Efficacy and Safety of the Omnipod 5 System in People With Type 2 Diabetes Undergoing HaemodialysisWho this might be right forType 2 DiabetesChronic Kidney Disease 5D Imperial College London 84
Not applicableNot Yet RecruitingNCT07786571What this trial is testingStudy on Improving Blood Glucose Homeostasis With Dorzagliatin Tablets in the Treatment of Type 2 Diabetes Mellitus Patients With Moderate to Severe Chronic Renal InsufficiencyWho this might be right forType 2 Diabetes Mellitus (T2DM)Chronic Renal InsufficiencyChronic Kidney Disease (Stages 3b-5)+1 more Sun Yat-sen University 206
Testing effectiveness (Phase 2)Looking for participantsNCT07496177What this trial is testingA Mechanistic Study on the Effect of HTD1801 Versus Placebo on Kidney Function in Patients With Type 2 Diabetes and Chronic Kidney Disease.Who this might be right forT2DMCKD Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences 75
Not applicableStudy completedNCT02608177What this trial is testingContinuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease - Changing Glucose ManagementWho this might be right forChronic Kidney DiseasesType 2 Diabetes University of Washington 3
Not applicableStudy completedNCT05526157What this trial is testingAn Observational Study, Called FINEGUST, to Learn More About How People With Chronic Kidney Disease and Type 2 Diabetes Are Treated and How the Introduction of New Treatment Options, Like Finerenone, Impacts Clinical PracticeWho this might be right forChronic Kidney DiseaseType 2 Diabetes Mellitus Bayer 50,000